2m 2m 2m 2m 2m 2m 2m
- $186.5MMarket Cap
- 42.61%1-Year Change
- Medical Instruments & SuppliesIndustry
KORU Medical Sys (KRMD)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 52
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
Cirtec Medical Announces Appointment of New Chief Executive Officer
Cirtec Medical has appointed Shar Matin as its new CEO, effective September 2, 2025. Matin brings over 25 years of global leadership experience in medical technology, previously serving as CEO of Cordis and holding executive roles at multiple medical technology companies.
08/28/2025, 12:59 PM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/03/2026
Company Profile
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
Key Executives
- Linda Tharby
- Thomas Adams
- Eric Schiller
- Adam Kalbermatten
- Christopher Pazdan
Current Ownership Distribution
- Institutions344.6M (80.89%)
- Mutual Funds62.0M (14.56%)
- Insiders19.4M (4.56%)
- Other0 (0.00%)